Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a140eb40d1e7437d8b8ea7e32eb9785d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb7ce8745175865c6357f7d5fe7fccf5 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76326f6add5e68c15c28188ad0ae80ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_288ba0706c8e6041dcb225e2921469e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25be3de6a830593091e0f909c881b11c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db254bc4183e6dcec8a0db92dec4c8d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad905a387be0e3ebf4c0ed95501ab1a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdfd603d274184061ef4baada8d440d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc044ed1b8d747185ac97066a443358 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a334778c15fef43d7349d6aa727d22cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c6feb8b6d7d5cc57bd01c8e3286be9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_584b99f3705a1972d0cd96ba9a385329 |
publicationDate |
2017-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2016208353-B2 |
titleOfInvention |
Immunotherapy regimes dependent on ApoE status |
abstract |
IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUS Abstract The invention provides methods of immunotherapy of Alzheimer's and similar diseases in which the regime administered to a patient depends on the ApoE genotype of 5 the patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020023530-A3 |
priorityDate |
2007-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |